NEWS

WIRES

OTHER

Herbalpharm Inc. Completes Merger

HerbalPharm, Inc. a Florida biotechnology company company ("HPF"), today announced the closing of its merger with HerbalPharm, Inc., a Washington company ("HPW"), in exchange for 20,713,000 restricted shares of HBPM.

The company's key products, Restorade(TM) and Stamina Solutions(TM), contain a unique compound that, through scientific research, demonstrated the ability to "reverse mitochondrial decay due to aging." Mitochondrial decay is a current and popular theory as a leading cause of aging related conditions.

The Restorade and Stamina Solutions products are the result of over 15 years of research and development at Hong Kong University of Science and Technology (HKUST), a founding shareholder of HPW. The research and development is led by Dr. Robert Ko, associate professor of the Biochemistry Department at HKUST, also a founding shareholder of HPW. HKUST is a world-class research university ranked # 60 worldwide by the Newsweek Magazine.

About HerbalPharm, Inc.

HerbalPharm, Inc. is a biotechnology company in the research and development, marketing, and sales of drugs, dietary supplements, and functional beverages. The initial products are based on a newly discovered compound (the "Compound"), which is the result of over 15 years of research and development by one of its founding shareholders, the Hong Kong University of Science and Technology ("HKUST").

At HKUST, scientific studies have identified biochemical actions of Herbalpharm's key Compound, demonstrating that it enhances the mitochondrial glutathione antioxidant status, a crucial factor in maintaining mitochondrial function and cell survival and induces the expression of heat shock proteins, another group of important molecules for cell protection. Management's research indicates that these biochemical actions are unique when compared to any existing compounds, either synthetic or naturally occurring, in protecting organs including the heart, the liver and the brain.

HerbalPharm aims to address, with its unique products, the aging concerns of the baby boomers, the heart-health and heart-diseases markets, and the segment of the population that is physically active. With its products (to be marketed under HerbalPharm(TM)) HerbalPharm, Inc., believes that it is positioned to become a formidable player in the biotech industry. The public company has a post merger capitalization of 28,469,298 shares of common stock issued and outstanding.

Forward-Looking Statements

This news release includes forward-looking statements that are made pursuant to the safe harbor provisions of the Private Securities Litigation Reform Act of 1995. While these statements are made to convey to the public the company's progress, business opportunities and growth prospects, readers are cautioned that such forward-looking statements represent management's opinion. Whereas management believes such representations to be true and accurate based on information and data available to the company at this time, actual results may differ materially from those described. Additional factors that could materially affect these forward-looking statements and/or predictions include, among other things: (1) ability to manage the HPW acquisition and the expansion of operations; (2) ability to obtain contracts with suppliers of raw materials and distributors of products; (3) the risks inherent in the mutual performance of such supplier and distributor contracts (including production performance); (4) ability to protect and defend proprietary technology; (5) ability to secure and retain management capable of managing growth; (6) our ability to raise necessary financing to execute the company's business plans; and (7) ability to comply with all applicable federal, state and local government and international rules and regulations.

News Preparation by EquityDigest.com.
HTML: http://www.eworldwire.com/pressreleases/16098
PDF: http://www.eworldwire.com/pdf/16098.pdf
ONLINE NEWSROOM: http://www.eworldwire.com/newsroom/311055.htm
RSS NEWSROOM: http://newsroom.eworldwire.com/xml/newsrooms/311055.xml

     
   President/CEO
   HerbalPharm, Inc.
   Seattle,    WA,    98101
   USA
   (206) 838-9739 (phone)